Trexquant Investment LP Repare Therapeutics Inc. Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$8.16 - $13.01 $216,044 - $344,452	-26,476 Reduced 47.34%	29,456 $355,000
Q2 2023 Aug 11, 2023	SELL	$8.63 - $12.53 $277,937 - $403,541	-32,206 Reduced 36.54%	55,932 $591,000
Q1 2023 May 15, 2023	BUY	$9.32 - $15.06 $144,646 - $233,731	15,520 Added 21.37%	88,138 $867,000
Q4 2022 Feb 13, 2023	SELL	$12.5 - $18.13 $88,200 - $127,925	-7,056 Reduced 8.86%	72,618 $1.07 Million
Q3 2022 Nov 14, 2022	BUY	$11.57 - $15.59 $329,131 - $443,488	28,447 Added 55.53%	79,674 $966,000
Q2 2022 Aug 11, 2022	BUY	$8.45 - $14.84 $432,868 - $760,208	51,227 New	51,227 $717,000
Q1 2022 May 13, 2022	SELL	$11.38 - $21.88 $231,389 - $444,886	-20,333 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$19.66 - $28.11 $114,362 - $163,515	5,817 Added 40.07%	20,333 $429,000
Q3 2021 Nov 12, 2021	BUY	$25.71 - $35.24 $373,206 - $511,543	14,516 New	14,516 $381,000

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $55.4M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.